Search Results - "Journal der Deutschen Dermatologischen Gesellschaft"

Refine Results
  1. 1
  2. 2
  3. 3

    JAK‐inhibitors in dermatology – small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects by Klein, Benjamin, Treudler, Regina, Simon, Jan C.

    “…Summary Numerous chronic inflammatory skin diseases are associated with the release of proinflammatory cytokines, which act via the intracellular JAK‐STAT…”
    Get full text
    Journal Article
  4. 4

    Anatomy of the Facial Fat Compartments and their Relevance in Aesthetic Surgery by Cotofana, Sebastian, Lachman, Nirusha

    “…Summary Objective There has been a significant shift in the understanding of facial anatomy during the last decade. Newer minimally invasive therapeutic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Leprosy – an overview of clinical features, diagnosis, and treatment by Fischer, Marcellus

    “…SummaryLeprosy is a chronic infectious disease caused by Mycobacterium (M.) leprae. Worldwide, 210,758 new cases were diagnosed in 2015. The highest incidence…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Chronic venous insufficiency – a review of pathophysiology, diagnosis, and treatment by Santler, Bettina, Goerge, Tobias

    “…Summary Chronic venous disease is a common disorder associated with a variety of symptoms in later disease stages but also with complications such as venous…”
    Get full text
    Journal Article
  11. 11

    Current developments and perspectives in psoriasis by Schön, Michael P., Wilsmann‐Theis, Dagmar

    “…Summary The study of psoriasis has yielded fundamental new insights into immunologic regulation and innovative therapies in a way that few other diseases have…”
    Get full text
    Journal Article
  12. 12

    Dyskeratosis congenita: a literature review by AlSabbagh, Manahel Mahmood

    “…Summary Dyskeratosis congenita is a rare hereditary disease that occurs predominantly in males and manifests clinically as the classic triad of reticulate…”
    Get full text
    Journal Article
  13. 13

    S1 guidelines: Lipedema by Reich‐Schupke, Stefanie, Schmeller, Wilfried, Brauer, Wolfgang Justus, Cornely, Manuel E., Faerber, Gabriele, Ludwig, Malte, Lulay, Gerd, Miller, Anya, Rapprich, Stefan, Richter, Dirk Frank, Schacht, Vivien, Schrader, Klaus, Stücker, Markus, Ure, Christian

    “…Summary The present, revised guidelines on lipedema were developed under the auspices of and funded by the German Society of Phlebology (DGP). The…”
    Get full text
    Journal Article
  14. 14

    Diagnosis and treatment of xerosis cutis – a position paper by Augustin, Matthias, Wilsmann‐Theis, Dagmar, Körber, Andreas, Kerscher, Martina, Itschert, Götz, Dippel, Michaela, Staubach, Petra

    “…Summary Background and rationale Xerosis cutis (also referred to as xeroderma, dry skin, asteatosis) affects more than 10 million individuals in Germany. It is…”
    Get full text
    Journal Article
  15. 15

    S1 Guideline: Diagnosis and therapy of vitiligo by Böhm, Markus, Schunter, Jo Ana, Fritz, Klaus, Salavastru, Carmen, Dargatz, Sonja, Augustin, Matthias, Tanew, Adrian

    “…Summary Vitiligo is a common skin disorder characterized by immune‐mediated destruction of melanocytes. Non‐segmental vitiligo, the most common clinical…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Sjögren’s syndrome by André, Fiona, Böckle, Barbara C.

    “…Summary Sjögren’s syndrome (SjS) is an autoimmune disease characterized by the triad of sicca symptoms, fatigue and pain. This diagnosis is usually made in…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment by Mastorino, Luca, Dapavo, Paolo, Susca, Sara, Cariti, Caterina, Siliquini, Niccolò, Verrone, Anna, Stroppiana, Elena, Ortoncelli, Michela, Quaglino, Pietro, Ribero, Simone

    “…Summary Background Biologics targeting IL‐23 and IL‐17 show efficacy and safety in the treatment of moderate‐to‐severe psoriasis. Objective To investigate drug…”
    Get full text
    Journal Article